NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
3.16
Dollar change
0.00
Percentage change
0.00
%
Index- P/E- EPS (ttm)-1.84 Insider Own24.31% Shs Outstand10.78M Perf Week2.93%
Market Cap34.08M Forward P/E- EPS next Y-1.96 Insider Trans-10.75% Shs Float8.16M Perf Month0.96%
Enterprise Value14.55M PEG- EPS next Q-0.44 Inst Own11.37% Short Float3.38% Perf Quarter-10.99%
Income-19.88M P/S- EPS this Y4.66% Inst Trans-15.29% Short Ratio5.18 Perf Half Y1.12%
Sales0.00M P/B2.03 EPS next Y-6.52% ROA-65.35% Short Interest0.28M Perf YTD-0.94%
Book/sh1.56 P/C1.73 EPS next 5Y-2.53% ROE-75.66% 52W High6.12 -48.35% Perf Year-26.00%
Cash/sh1.83 P/FCF- EPS past 3/5Y-19.42% -37.87% ROIC-118.25% 52W Low2.55 23.92% Perf 3Y-36.03%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility4.56% 5.40% Perf 5Y-72.62%
Dividend TTM- EV/Sales- EPS Y/Y TTM-13.72% Oper. Margin- ATR (14)0.21 Perf 10Y-
Dividend Ex-Date- Quick Ratio4.86 Sales Y/Y TTM- Profit Margin- RSI (14)46.11 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio4.86 EPS Q/Q16.94% SMA20-2.00% Beta1.53 Target Price25.00
Payout- Debt/Eq0.01 Sales Q/Q- SMA50-7.68% Rel Volume0.00 Prev Close3.16
Employees24 LT Debt/Eq0.00 EarningsMay 15 BMO SMA200-13.62% Avg Volume53.30K Price3.16
IPOJun 11, 2020 Option/ShortYes / Yes EPS/Sales Surpr.14.29% - Trades Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Oct-07-21Initiated H.C. Wainwright Buy $32
Jun-16-25 08:30AM
May-29-25 11:21PM
08:30AM
May-15-25 08:45AM
May-12-25 09:00AM
08:31AM Loading…
08:31AM
May-08-25 08:30AM
May-05-25 08:55AM
08:31AM
Apr-01-25 09:01PM
Mar-27-25 08:35PM
04:01PM
Mar-20-25 08:00AM
Mar-12-25 06:00AM
Feb-20-25 04:14PM
08:00AM Loading…
Feb-19-25 08:00AM
Jan-27-25 06:54PM
07:55AM
Jan-17-25 01:29PM
Dec-10-24 10:40AM
Dec-09-24 12:21PM
08:15AM
Dec-07-24 01:59AM
Dec-03-24 08:00AM
Nov-26-24 08:45AM
Nov-19-24 08:00AM
Nov-08-24 06:03PM
Nov-07-24 04:05PM
Nov-05-24 08:00AM
Oct-31-24 08:00AM
08:45AM Loading…
Oct-23-24 08:45AM
Oct-21-24 08:00AM
Oct-15-24 09:07AM
Oct-09-24 05:56PM
Sep-23-24 08:00AM
Aug-31-24 02:02PM
Aug-08-24 04:01PM
Aug-07-24 09:31AM
Aug-05-24 08:00AM
Aug-01-24 08:00AM
Jul-10-24 08:30AM
Jun-12-24 07:30AM
May-23-24 11:51AM
May-09-24 04:02PM
May-06-24 06:41AM
04:37AM
03:00AM
May-02-24 07:30AM
May-01-24 06:00AM
Apr-24-24 08:00AM
Apr-22-24 08:12AM
Apr-10-24 08:45AM
Mar-20-24 09:00AM
Mar-19-24 09:06AM
Mar-18-24 08:53PM
05:32PM
04:02PM
Mar-15-24 08:00AM
Mar-11-24 07:30AM
Mar-07-24 06:17AM
Mar-05-24 08:01AM
Mar-04-24 08:01AM
Feb-20-24 08:01AM
Feb-15-24 08:01AM
Jan-17-24 07:30AM
Dec-13-23 08:05AM
Nov-30-23 08:00AM
Nov-10-23 11:31AM
Nov-08-23 06:43PM
04:01PM
Nov-01-23 08:00AM
Oct-24-23 04:03PM
Oct-10-23 08:00AM
Oct-03-23 08:00AM
Sep-29-23 07:40AM
Sep-25-23 08:30AM
Sep-18-23 09:00AM
Sep-14-23 09:09AM
Aug-31-23 08:00AM
Aug-28-23 05:32PM
08:00AM
Aug-23-23 06:00PM
Aug-14-23 08:30AM
Aug-10-23 08:37AM
Aug-09-23 04:01PM
09:11AM
Aug-08-23 03:06PM
Aug-02-23 12:45PM
08:00AM
Aug-01-23 07:30PM
Jul-30-23 02:45PM
Jul-17-23 08:00AM
Jun-26-23 08:30AM
Jun-12-23 08:30AM
Jun-08-23 09:00AM
May-19-23 06:50AM
May-17-23 08:00AM
May-10-23 09:59AM
May-09-23 04:01PM
May-03-23 09:00AM
Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fletcher Aaron G.L.10% OwnerJun 13 '25Sale3.0940,000123,60049,957Jun 13 07:57 PM
Kreis Leslie W.10% OwnerJun 13 '25Sale3.0940,000123,60049,957Jun 13 07:50 PM
Fletcher Aaron G.L.10% OwnerJun 12 '25Sale3.3860,647204,98751,860Jun 13 06:06 AM
Fletcher Aaron G.L.10% OwnerJun 11 '25Sale3.409503,23054,746Jun 13 06:06 AM
Fletcher Aaron G.L.10% OwnerJun 10 '25Sale3.40165454,791Jun 13 06:06 AM
Kreis Leslie W.10% OwnerJun 12 '25Sale3.3860,647204,98751,860Jun 13 06:01 AM
Kreis Leslie W.10% OwnerJun 11 '25Sale3.409503,23054,746Jun 13 06:01 AM
Kreis Leslie W.10% OwnerJun 10 '25Sale3.40165454,791Jun 13 06:01 AM
Fletcher Aaron G.L.10% OwnerMay 27 '25Sale3.0521,03764,16356,467May 29 09:55 PM
Fletcher Aaron G.L.10% OwnerMay 29 '25Sale3.0320,20061,20654,792May 29 09:55 PM
Fletcher Aaron G.L.10% OwnerMay 28 '25Sale2.8715,00043,05055,753May 29 09:55 PM
Kreis Leslie W.10% OwnerMay 27 '25Sale3.0521,03764,16356,467May 29 09:53 PM
Kreis Leslie W.10% OwnerMay 29 '25Sale3.0320,20061,20654,792May 29 09:53 PM
Kreis Leslie W.10% OwnerMay 28 '25Sale2.8715,00043,05055,753May 29 09:53 PM
Bios Fund II, LPAffiliate (10% owner)May 27 '25Proposed Sale3.2953,454175,864May 27 09:00 PM
Bios Fund I QP, LPAffiliate (10% owner)May 27 '25Proposed Sale3.2929,57697,305May 27 08:58 PM
Bios Fund II NT, LPAffiliate (10% owner)May 27 '25Proposed Sale3.2925,84985,033May 27 08:56 PM
Bios Fund I, LPAffiliate (10% owner)May 27 '25Proposed Sale3.2975,941249,846May 27 08:55 PM
Bios Fund II QP, LPAffiliate (10% owner)May 27 '25Proposed Sale3.29105,180346,042May 27 08:53 PM